Lv11
60 积分 2024-08-08 加入
Multispecific T-cell engagers attract cancer drug developers
2小时前
待确认
xTrimoPGLM: unified 100-billion-parameter pretrained transformer for deciphering the language of proteins
3个月前
已完结
One Pivotal Trial, the New Default Option for FDA Approval — Ending the Two-Trial Dogma
4个月前
已完结
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
10个月前
已完结
皖公网安备34019202002308
